StockWatch
·
Pharmaceuticals
Quarterly Result23 Jan 2026, 03:53 pm

Shree Ganesh Remedies Ltd. Announces Q3 and Nine Months Financial Results for 2025

AI Summary

The Board of Directors of Shree Ganesh Remedies Ltd. has approved the unaudited financial results (standalone and consolidated) for the quarter and nine months ended on December 31, 2025. The company's total revenue for the quarter ended December 31, 2025, was NIL lakhs and the total net profit/ (loss) after tax was (0.95) lakhs. The meeting of the Board of Directors commenced at 2:45 p.m. and concluded at 03:35 p.m. The review report was submitted by Chaudhary Shah & Associates LLP, the independent auditor of the entity.

Key Highlights

  • Shree Ganesh Remedies Ltd. announced its unaudited financial results for Q3 and nine months ended on December 31, 2025.
  • The company's total revenue for the quarter ended December 31, 2025, was NIL lakhs.
  • The total net profit/ (loss) after tax for the quarter ended December 31, 2025, was (0.95) lakhs.
  • The review report was submitted by Chaudhary Shah & Associates LLP, the independent auditor of the entity.
  • The meeting of the Board of Directors commenced at 2:45 p.m. and concluded at 03:35 p.m.